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Abstract 
Prematurity and fetal growth restriction are frequent conditions associated with adverse 
neurocognitive outcomes. We have previously identified early deregulation of genes 
controlling neuroinflammation as a putative mechanism linking fetal growth restriction and 
abnormal trajectory of the developing brain. While the oxytocin system was also found to be 
impaired following adverse perinatal events, its role in the modulation of neuroinflammation 
in the developing brain is still unknown. We used a double-hit rat model of perinatal brain 
injury induced by gestational LPD and potentiated by postnatal injections of subliminal doses 
of IL1β and a zebrafish model of neuroinflammation.  Effects of the treatment with 
carbetocin, a selective, long lasting and brain diffusible, oxytocin receptor agonist have been 
assessed using a combination of histological, molecular and functional tools in vivo and in
vitro. In the double hit model, white matter inflammation, deficient myelination and 
behavioral deficits have been observed and the oxytocin system was impaired. Early 
postnatal supplementation with carbetocin alleviated microglial activation at both 
transcriptional and cellular levels and provided long-term neuroprotection. The central anti-
inflammatory effects of carbetocin have been shown in vivo in rat pups and in a zebrafish 
model of early-life neuroinflammation and reproduced in vitro on stimulated sorted primary 
microglial cell cultures from rats subjected to LPD. Carbetocin treatment was associated with 
beneficial effects on myelination, long-term intrinsic brain connectivity and behavior.
Targeting oxytocin signaling in the developing brain may be an effective approach to prevent 
neuroinflammation – induced brain damage of perinatal origin.
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Main points 
- A double-hit insult model of perinatal brain injury was found associated with low 
expression of Oxytocin, exacerbated microglial activation and defective myelination. 
- A long-lasting Oxytocin receptor agonist regulates microglial reactivity and provides long-
term neuroprotection. 
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Introduction 
Neurocognitive disabilities of perinatal origin remain a major burden on children, their families 
and society, underscoring the need to develop preventive strategies (Katz et al., 2013) 
(Christensen et al., 2014). Prematurity and fetal growth restriction (FGR), affecting 15-20% of 
all pregnancies, are the two leading causes of these learning disabilities and developmental 
behavioral disorders (Guellec et al., 2015; Hack et al., 2002; Jarvis et al., 2003).  
Inflammation in the central nervous system plays a key role in the pathophysiology of 
perinatal brain damage observed in both animal models and human neonates (Hagberg, 
Gressens, & Mallard, 2012). Although the mechanisms involved in inflammation-induced 
early brain injury remain unclear, recent evidences have shown that abnormal microglial 
activation can contribute to white matter damage, neurocognitive disabilities and 
neuropsychiatric disorders in children and adults (Leviton, Dammann, & Durum, 2005; 
Rezaie & Dean, 2002). These findings have been documented not only in models inducing 
neuroinflammation in neonatal animals (Favrais et al., 2011) but also in rat pups subjected to 
FGR, where extensive deregulation of genes controlling neuroinflammation in microglial cells 
has been recently reported (Rideau Batista Novais et al., 2016). Therefore, the regulation of 
neuroinflammation early in life offers a relevant approach to neuroprotection.  
In addition to inflammation, perinatal stress associated with prematurity or FGR has been 
associated with disturbances in the hypothalamic–pituitary–adrenal (HPA) axis and with 
reduced oxytocin (OXT) expression in the hypothalamic paraventricular nucleus (Feldman, 
2015; Lee, Brady, Shapiro, Dorsa, & Koenig, 2007; Moisiadis & Matthews, 2014). Oxytocin 
can facilitate a variety of social activities ranging from pair bonding to maternal behavior, 
which can be impaired by unexpected perinatal events, including prematurity (Alkozei, 
McMahon, & Lahav, 2014). This hormone is also involved in the function of GABA neurons, 
in autistic-like behavior in adulthood (Romano, Tempesta, Micioni Di Bonaventura, & 
Gaetani, 2015; Tyzio et al., 2014), and in social neuroprotection after cerebral ischemia 
(Karelina et al., 2011). Finally, OXT has peripheral and central anti-inflammatory effects in 
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adult (Li, Wang, Wang, & Wang, 2016; Yuan et al., 2016), but little is known about its impact 
on the developing brain. 
Here, we hypothesize that OXT could influence microglial activation in response to perinatal 
brain injury and mitigate the ensuing damage. To address this issue, we used a rat model 
mimicking the most frequent perinatal injury affecting the human brain and a zebrafish model 
of microglia overactivation to investigate the effect of carbetocin, a long-lasting OXT receptor 
(OXTR) agonist, on neuroinflammation and its developmental consequences.  
Materials and Methods 
Animals, diets and postnatal inflammatory challenge 
All experiments were carried out in compliance with INSERM ethical rules, approved by the 
institutional review board (Bichat-Robert Debré ethics committee, Paris, France, approval 
number 2010-13/676-0010) and following the rules of the European Communities Council 
Directive 2010/63/EU. Sprague-Dawley dams (Janvier SAS, France) were randomly divided 
into two groups according to their diet: a normal 22% protein diet (control, Ctl) or an 
isocaloric 9% protein diet (LPD) from the day of conception until delivery, as previously 
described(Zana-Taieb et al., 2015). At postnatal day 1 (P1) and P2, pups were injected intra-
peritoneally (i.p.) twice a day with PBS or carbetocin (1mg/kg, H-5832, Bachem®, 
Switzerland) for control animals whereas LPD animals received recombinant IL1β (20µg/kg, 
R&D Systems, Minneapolis, MN) alone or in combination with carbetocin (1mg/kg).  
Neural Tissue Dissociation and Magnetic-Activated Cell Sorting 
Brains were collected for cell dissociation and microglial cell were enriched using a magnetic-
bead-coupled antibody (anti-CD11b) extraction technique (MACS), according to the 
manufacturer’s protocol (Miltenyi Biotec, Germany)(Rideau Batista Novais et al., 2016). 
Microglial cells were sorted at P2 (primary culture, 2 brains per sorting) or P4 (micro-array 
analysis, 1 brain per sorting).  
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RNA Preparation, cDNA Synthesis, Microarray Hybridization, and Bioinformatics 
Analysis 
Total RNA was extracted from purified microglia of each P4 animal, cDNA synthesis and 
microarray hybridization were performed as previously described(Rideau Batista Novais et 
al., 2016). For microarray hybridization, labeled cRNA was generated using classical 
protocols for Affymetrix array hybridization. Three points per condition were analyzed using 
RaGene-2_0-st microarray hybridization, 36685 probes are examined and directly analyzed 
using Gene Set Enrichment Analysis (GSEA; 
http://software.broadinstitute.org/gsea/index.jsp) (Subramanian et al., 2005). The microarrays 
were also analyzed as networks built using string (http://string-db.org/). The numerical data 
from the network were then exported to Cytoscape for the hub genes analysis. To validate 
the microarray observations, qRT-PCR has been performed on 12 up or down regulated 
genes (N=8-10 samples from two litters). 
RNA Purification for Real-Time PCR on cortical samples 
For qRT-PCR quantification, cortical samples were immediately snap-frozen in liquid nitrogen 
from 8 to 10 pups from three litters. Total RNA was extracted with the RNeasy mini kit 
(Qiagen, France) and one mg was subjected to reverse transcription using the IscriptTM 
cDNA synthesis kit (Bio-Rad, France). qRT-PCR was performed in duplicate for each sample 
as previously described (Favrais et al., 2011). Primers were designed using Primer3 software 
and manufactured by Eurofins Genomics (Germany). GAPDH was used as reference gene. 
Analyses were performed using Bio-Rad CFX Manager 3.0. 
Microglia primary culture 
Experiments were conducted in 3 separate experiments with a total of 9 control mothers (64 
P2 pups) and 10 LPD mothers (66 P2 pups). After cell sorting microglia were cultured in 
DMEM F-12 medium (10% FBS). After 48h Ctl and LPD cells were divided in four 
experimental groups for mRNA analysis and treated with 1) PBS, 2) IL1β (50ng/ml)+INFγ 
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(20ng/ml) (R&D Systems, Minneapolis, MN) for 4h, 3) carbetocin (1µg/ml ≈ 1µM) for 1h plus 
IL1β (50ng/ml)+INFγ (20ng/ml) for 4h, 4) L-368,899 (Tocris, France) (2µM) for 10 minutes 
plus carbetocin (1µg/ml ≈ 1µM) for 1h and IL1β (50ng/ml)+INFγ (20ng/ml) for 4h. For 
morphological analysis, groups 1-3 were included in the analysis after 9h drug exposure. 
For qRT-PCR total RNA was extracted using the NucleoSpin RNA Plus extraction kit 
(Macherey-Nagel, France). Reverse transcription and qPCR measurements were performed 
as described above with the Ribosomal protein L13 (Rpl13) and Hypoxanthine 
Phosphoribosyltransferase (Hprt) as reference genes. 
Cytokines concentrations in cell culture medium were measured by multiplex Luminex assay 
(171K1002M Bio-Plex Pro Rat Cytokine TH1/TH2, Biorad, France). 
For morphological analysis, after a 4% PFA fixation, cells were stained with a goat anti-Iba1 
and Iba1+ cells were analyzed using a fluorescent microscope (Nikon Eclipse Ti-E). Between 
190 and 243 single cells/group have been analyzed and the following morphological 
parameters have been evaluated: 1) Cells Area, 2) Cells perimeter, 3) Cells sphericity using 
the relation 4π× (area/perimeter2). Control cells (Ctl, PBS) were divided in three size groups 
on the base of cells area: 1) <31µm², 2) 31<µm²>45, 3) >45µm² and the percentage of cells 
for each size group and for each experimental condition was calculated. 
Immunohistochemistry 
In each experimental group, we studied 8 to 10 pups from at least two litters on postnatal 
days P4 for Iba1, and on P10 for MBP, APC and Olig2 as previously described (Rideau 
Batista Novais et al., 2016). 
Functional Ultrasound (fUS) Imaging of Intrinsic Brain Connectivity in Living Rats 
Resting state fUS imaging was performed at P28 on 7-9 rats from two litters in each group as 
previously described by Rideau et al., 2016, extending the number of brain area (ROI) from 
10 to 20 (see Fig. 6A). 
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Behavioral assessment 
One-month old Control and LPD+IL1β rats (treated or not with carbetocin, 6 per group) were 
placed individually into the Open Field, 50×50 cm square brightly illuminated (400 lx) arena. 
The exploratory behavior of the animal was tracked using Ethovision video tracking 
equipment and software (Noldus, The Netherlands) for 10 min.  
Two-months old rats (9 to 11 animals per group) were tested using a 2-trial memory task 
between 9 am and 3 pm, in a Y-maze as previously described(Dellu, Mayo, Cherkaoui, Le 
Moal, & Simon, 1992) with a 6 hours inter-trial interval between the 15 min acquisition and 
the 5 min retention phases.  
Zebrafish experiments 
Zebrafish were maintained at 26.5°C in 14/10 light/dark cycles. Developmental stages were 
determined as hours post-fertilization (hpf) or days post-fertilization (dpf) as previously 
described (Kimmel, Ballard, Kimmel, Ullmann, & Schilling, 1995). The transgenic line 
Tg[Apo-E-GFP] was previously described(Peri & Nusslein-Volhard, 2008) and all 
experiments were  approved  by the French Animal Ethics Committee in accordance with the 
ethics statement n°2012-15/676-0069. 
Dechorionated 24 hpf embryos were first incubated in 12-well culture plates for 5 days with 
hydrocortisone (1.3 µM). Then, carbetocin (1 µM) was added to the hydrocortisone solution 
and embryos were incubated for an additional 48-hour period. As controls, embryos were 
treated with carbetocin alone, or E3 medium. All solutions were changed daily. All 
experiments were conducted on 8 dpf larvae (Fig. 4A).  
Specific mRNA levels (15 larvae for each batches) were evaluated after normalization with 
beta-actin mRNA. 
Fluorescent images were captured using a Leica SP8 confocal scanning laser microscope 
(20x/0.75 objective) and an Olympus (40x/1.1 objective). Images were analyzed using both 
Imaris 8.4.0 (Bitplane Inc.) and Fiji 2.0.0 (NIH Fiji open-source) softwares. Quantifications 
were performed using images from three independent experiments. The surface, volume and 
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) of microglial cells were quantified using the Imaris MeasurementPro 
software (Bitplane Inc.). The speed (distance travelled per unit of time) and displacement 
(distance between first and last positions) of microglia processes were analyzed using the 
Imaris Filament tracer software (Bitplane Inc.).  
Statistical Analysis 
All data are reported as means±S.E.M. Statistical analysis of all data was performed using 
GraphPad PRISM version 6.0 (San Diego, CA). T-test was performed for two groups 
comparisons. For more than 2 groups, a one- or two- way ANOVA followed by a Newman 
Keul’s post hoc multiple comparison tests was performed. For the open field analysis, 
comparison of activity between the various zones for the four experimental groups was 
performed using two-way ANOVA for repeated measure followed by Bonferroni multiple 
comparison tests. Significance was set at P < 0.05 for all tests. Detailed numbers, t-, F- and 
P-values were reported on supplementary Table 1. 
Results 
Deregulation of OXT system and microglial activation in response to a double-hit 
model of perinatal brain injury 
We first refined a rat model based on a gestational low protein diet (LPD) inducing FGR 
(Rideau Batista Novais et al., 2016) by combining antenatal LPD and postnatal low-dose 
IL1β injections to mimic pro-inflammatory events commonly associated with brain damage 
and neurocognitive impairments (Leviton et al., 2013) (Fig. 1A). In this double-hit model, 
early imbalance towards excessive HPA-related hormones and lower expression of OXT was 
observed in the hypothalamus at P1 (Fig. 1B). OXTR gene expression was also found 
upregulated in hypothalamus but neither in cortex nor in microglial cells sorted from 
challenged animals. Cortical brain injury induced upregulation of several genes encoding for 
Page 11 of 54
12
pro-inflammatory cytokines at P2 and P4 and defective myelination at P10. No gender-
related vulnerability to brain damage was observed in this model. 
Transcriptomic analyses revealed that the low-dose IL1β treatment used in the model did not 
trigger substantial effects on gene expression of sorted microglial cells from P4 rat pups 
versus controls (Fig. 1C). In contrast, a synergistic effect of the double-hit (antenatal LPD 
plus postnatal IL1β) was observed especially in up-regulated gene sets related to 
inflammation (Fig. 1C-1E). Gene Set Enrichment Analysis (GSEA) showed an enrichment of 
several "hallmark" gene sets involved in the inflammatory response, in line with the 
immunohistological results (Fig. 1F).  
Then, transcriptomic data was studied for upregulated genes in response to a double hit 
insult using the network analysis tool Cytoscape (http://www.cytoscape.org/), after generating 
a network using String (http://string-db.org/). The network obtained, simplified by selecting 
“hub” genes known to be connected to several others, demonstrated a strongly enriched 
number of “edges” (gene-gene relations; 128 edges found while 43 were expected; p-value 
<10-100). Within biological processes, activation of immune signaling appeared almost 
exclusive (Fig. 1F, Table 1). The network analysis was centered on IL1β that appeared as 
the major hub gene (Fig. 1G). 
Effect of carbetocin on microglial activation in vivo. 
We next tested the hypothesis that OXT insufficiency could be involved in the perinatal brain 
damage observed in the model. We used carbetocin, a long-lasting brain-permeable OXTR 
agonist (Dvorska et al., 1992) simultaneously with low-dose IL1β on P1 and P2. Carbetocin 
treatment induced a significant reduction of Iba1+ microglial cell density within the developing 
white matter in LPD+IL1β P4 animals (Fig. 2A, 2B). Using qRT-PCR on cortex from P4 rat 
pups, carbetocin significantly prevented up-regulation of IL6, IL1β, TNFα and iNOS, all 
markers of classical cytotoxic microglial activation, in animals subjected to a double-hit insult 
(Fig. 2C). Conversely, carbetocin did not change the gene expression of alternate activation 
markers including Arg1, IGF1, Mrc1 and Sphk1. Focusing on the effects of carbetocin at the 
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transcriptional levels, microarray analysis revealed a 50% reduction in the number of genes 
up-regulated more than 1.5 fold (16 vs 32) in sorted microglial cells from animals treated with 
carbetocin compared to untreated animals (Fig. 2D, 2E). Up-regulated genes network based 
on gene expression of the microglial cells isolated from animals treated by carbetocin 
included IL10, CXCL2, NOS2 and NCAM1 genes involved in the induction or regulation of 
brain inflammation (Fig. 2F). Interestingly, the main gene sets involved in the inflammatory 
which are up-regulated in the double hit model were systematically found to be down-
regulated by carbetocin treatment (Fig. 2G). Looking at the “TNFα signaling via NFκB 
cascade” gene set in more details, we isolated the subset of core genes composed of 57 
genes that were up-regulated 1.41-fold in LPD+IL1β animals and down-regulated 0.81-fold 
by carbetocin treatment. The product of the inductions for each gene yielded an induction 
ratio of 1.14, not significantly different from 1 (Fig. 2H).  
Effect of carbetocin on FGR-associated microglial activation in vitro  
To further investigate the direct effect of carbetocin on microglial activation in vitro, we 
studied microglial cells sorted from P2 animals subjected to LPD and controls, with and 
without in vitro pro-inflammatory exposure to IL1β+INFγ. Forty-eight hours after sorting and 
plating, pure microglial cell cultures were stained using Iba1 (Fig. 3A). A marked increase in 
the concentrations of several pro-inflammatory cytokines was detected in the culture medium 
of sorted primary microglia from LPD-exposed animals (Fig. 3B). The exposure to LPD 
induced significant changes in microglial cell morphology with a reduced cell surface area, a 
reduced cell perimeter and increased cell circularity, all markers of microglial activation (Fig. 
3C-3E). Pro-inflammatory challenge induced cell morphology changes towards amoeboid 
shape in control cells but not in LPD-derived cells that showed an activated profile already in 
basal condition. In both cell groups, carbetocin was able to significantly alleviate microglial 
activation (Fig. 3C, 3D). Gene expression of microglial activation markers were assessed in 
sorted primary microglial cultured cells from LPD brains and controls under basal conditions 
and after IL1β+INFγ stimulation in the presence or absence of carbetocin alone or in 
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combination with OXTR antagonist L-368-899 (Fig. 3F). A 4-fold increase in the expression 
of all cytotoxic markers was detected in microglial cells from LPD brain both under basal 
conditions and after stimulation. Carbetocin was able to partially prevent microglial over-
activation in response to pro-inflammatory stimulus. L-368-899 significantly reversed this 
effect suggesting that the carbetocin effect on microglial activation in vitro was OXTR-
mediated. 
Effect of carbetocin on hydrocortisone-induced microglia activation in zebrafish 
embryos 
We further investigated the effect of carbetocin on microglia activation in vivo, using an 
established model of neuroinflammation induced by chronic hydrocortisone incubation of 
zebrafish larvae (Hartig, Zhu, King, & Coffman, 2016), applied to the Tg[ApoE:eGFP] 
zebrafish transgenic line (Peri & Nusslein-Volhard, 2008), which allows live imaging of 
microglial cells (Fig. 4A-4C).  
First, zebrafish embryos exposed to 1.3 µM hydrocortisone from 1 hpf to 7 days post-
fertilization (dpf), displayed evidence of microglial activation including a 3- to 6.7-fold 
increased expression of the pro-inflammatory cytokines IL1β, IL8 and TNFα (Fig. 4D) and a 
significant reduction in the number and length of microglia processes (Fig. 4E). Two-day 
treatment with 1 µM carbetocin did not induce any effect on cytokine expression and cell 
shape in controls but markedly attenuated the effects of hydrocortisone, with microglial cells 
recovering elongated processes and a ramified morphology, similar to that seen in non-
treated controls (Fig. 4D, 4E). The effects of hydrocortisone on microglia morphology were 
quantified using Imaris software (Bitplane Inc.) showing a significant increase of cell 
sphericity, marked decreases of their volume, surface area, and surface area/volume ratio, 
all effects reversed by carbetocin (Fig. 4F). We also performed in vivo time-lapse confocal 
imaging combined with image analysis and quantification to assess microglial cell dynamics 
using the Imaris software (Supplementary videos S1-S4). Hydrocortisone treatment induced 
significant increase in the mean speed of their processes and mean track displacement 
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measurements (Fig. 4G, 4H). Carbetocin strongly reduced the effects of hydrocortisone, 
resulting in quantitative measurements similar to those determined in control embryos.  
Long-term impact of carbetocin on myelination, in vivo brain connectivity and 
behavior 
We investigated whether carbetocin, by targeting neuroinflammation, could prevent brain 
damage and its long-term consequences in the present model of perinatal brain injury. 
Despite no detectable gross morphological damage, assessment of myelination at P10 
revealed a significant decrease in the myelin content (MBP+ fibers) and APC+ mature 
oligodendrocytes within the cingulate white matter and external capsule in animals subjected 
to a LPD+IL1β challenge (Fig. 5A, 5B). The total oligodendroglial population (Olig2+ cells) 
was found to be unaffected suggesting a disruption of the oligodendroglial lineage.  
Using functional ultrasound (fUS), computation of highly sensitive cerebral blood volume 
(CBV) maps related to underlying neuronal activity was recorded in animals at P28. Each 
brain imaging plane was co-registered with a rat brain atlas reference (Paxinos & Watson, 6th 
Ed., 2007) to compute average ROIs-based CBV signals that exhibit various degrees of 
correlation (Fig. 6A, 6B). Pearson correlation coefficients between inter- and intra-
hemispheric couples of ROIs were gathered into a matrix whose correlation levels and 
spatial patterns reflected a degree of cerebral connectivity that can be compared between 
groups (Fig. 6C). Inter-hemispheric somatosensory connectivity was significantly depressed 
in animals exposed to perinatal brain injury in the retrosplenial granular cortex (RSG), in a 
critical position between the hippocampal formation and the neocortex retrosplenial 
dysgranular cortex (RSD), medial and lateral parietal association cortex (LPtA, MPtA) and in 
most parts of the thalamic area (Fig. 6D). Carbetocin treatment prevented the loss of inter-
hemispheric connectivity in most of areas. Intra-hemispheric connectivity was also found to 
be severely impaired (Fig. 6E). Again, carbetocin was associated with the significant 
prevention of functional disorders involving RSD and the parietal association cortex. 
Finally, behavioral consequences of LPD+IL1β exposure and carbetocin treatment were 
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assessed in 28-day animals for open-field (OF) and 2-month animals for Y-maze tests. Track 
records in the OF were divided into three different zones from center to periphery of the 
arena (Fig. 7A, 7B). Animals subjected to LPD+IL1β spent significantly more time in the 
periphery of the arena than did control animals. They traveled a longer distance in the 
intermediate zone between the periphery and the center and their velocity was higher in the 
center, findings suggesting anxiety-like behavior (Fig. 7B). Carbetocin treatment fully 
prevented these behavioral alterations. In the Y-maze test, distance traveled during the first 5 
minutes of the habituation period was found to be significantly greater in animals subjected to 
the double-hit than in controls (Fig. 7C). Percentage of time spent in the novel arm during the 
retention task was significantly lower in LPD+IL1β animals, suggesting their incapacity to 
recognize novelty (Fig. 7D). These effects were consistently prevented by carbetocin 
treatment. 
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Discussion 
This study demonstrates that early postnatal activation of OXTR after birth is able to 
modulate microglial activity and is associated with a significant protection of the neonatal 
brain subjected to a pro-inflammatory challenge. Carbetocin reduced most of the effects, in 
particular microglial activation, observed in a double hit model of perinatal brain injury 
induced by gestational LPD and potentiated by postnatal injections of subliminal doses of 
IL1β. The central anti-inflammatory effects of carbetocin have been shown in vivo in rat pups 
and reproduced both in vitro on stimulated sorted primary microglial cell cultures from rats 
subjected to LPD and in vivo in a zebrafish model of early-life neuroinflammation. These 
findings were associated with in vivo effects on myelination, and on long-term brain 
connectivity and behavior. 
The present animal model was designed to be as relevant as possible considering the 
complexity of FGR in humans. Following birth, growth-restricted neonates are more prone to 
develop inflammatory-related damage resulting in cerebral palsy, cognitive and behavioral 
disorders (Miller, Huppi, & Mallard, 2016). The preclinical model used in the present study 
was set up to replicate both FGR and these inflammatory-related events frequently observed 
in human neonates. Recent findings have suggested that growth-restricted rats already show 
an exacerbated neuro-inflammatory response associated with damages to the developing 
brain (Campbell et al., 2012; Rideau Batista Novais et al., 2016). In this vulnerable context, a 
subliminal inflammatory challenge had a synergistic deleterious effect on the brain in growth-
restricted rat pups.  
Like many other models of perinatal stress, our model was found to be associated with an 
early imbalance between the HPA axis and the OXT system, two hypothalamic systems of 
crucial importance during brain development: exposure to a series of unpredictable stresses 
during the final week of pregnancy (Lee et al., 2007), repeated restrain stress(Mairesse et 
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al., 2015) or prenatal cocaine (Williams & Johns, 2014) induced in the offspring an elevation 
of CRH production concomitantly with reduced OXT levels in the hypothalamus. The role of 
this imbalance in the developmental programing of neuroinflammation remains to be clarified. 
As a first hypothesis, the decreased OXT system activity associated with an increased HPA 
axis activity could result in an early excessive exposure to glucocorticoids that could, by 
epigenetic mechanisms, permanently decrease the expression of glucocorticoid receptors 
(GR) in the immune cells including microglial cells. As a result, this enduring loss of anti-
inflammatory effects of endogenous glucocorticoids could shift the immune response toward 
a pro-inflammatory phenotype later in life (Vanbesien-Mailliot et al., 2007). 
Here we have demonstrated that the long-lasting OXTR agonist, carbetocin was able to 
block microglial overactivation associated with gestational LPD, not only in vivo but also 
directly in vitro. Similar anti-inflammatory effects of OXT have previously been reported in 
adults following the exposure of bacterial endotoxin (Clodi et al., 2008), or LPS in 
macrophages and endothelial cells (Szeto et al., 2008) and even in microglial cells (Yuan et 
al., 2016). The biological action of OTX is linked to the activation of OXTR, a selective seven-
transmembrane Gq/Gi-coupled receptor expressed both in astrocytes and in 
microglia(Karelina et al., 2011; Yuan et al., 2016), particularly in response to inflammation 
(Szeto et al., 2017). Indeed, exposure of microglia cells to inflammatory stimulus induced a 
time-dependent increase in OTXR expression suggesting that the sensitivity of microglia to 
OTX could be potentiated in response to an immune challenge.  
The molecular basis of the neuroprotective action of OTX remains unclear and modulation of 
the downstream ERK/MAPK pathway in microglial cells has been reported in only one 
study(Yuan et al., 2016). Alternative pathways could also be involved including other 
molecular effectors of OTXR (e.g. NFκB, eEF2 eukaryotic elongation factor 2) and could be 
linked to the modulation of the expression of other neurotransmitter receptors on the 
microglial surface membrane (Liu, Leak, & Hu, 2016). The gene expression profile corrected 
by carbetocin treatment concerns genes involved in many different stresses, including DNA 
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damage and apoptosis (Gadd45a), angiogenesis and coagulation (Vegfa, F3), inflammation  
(Rel, RelB, NFκB, IL1β). This concerted action could explain the various and sustained 
improvements observed in the treated animals. 
Interestingly, our findings were not restricted to rodents, but were replicated in optically 
transparent zebrafish embryos, not only on cell morphology or gene regulation but also on 
the dynamics of microglial cell processes. Altogether, these data demonstrate an 
evolutionarily conserved anti-inflammatory function of OXT-OXTR, which targets the 
microglia and markedly alleviates the differentiation of these cells towards an activated 
cytotoxic profile. 
Targeting neuroinflammation is critical in protecting the developing brain because both 
systemic and central inflammation play a role in the blockade of oligodendrocyte maturation 
leading to long-term myelination defects and finally cognitive defects in the neonate(Volpe, 
2009). In neonates born after FGR, the levels of circulating cytokines were found to be 
significantly increased on days 7 and 14 compared with levels measured in neonates without 
FGR (Leviton et al., 2013; McElrath et al., 2013). This postnatal systemic pro-inflammatory 
state following FGR could, at least in part, be responsible for the brain insults and 
neurodevelopmental impairments detected in childhood in these individuals.  
Microglia cells play a major role in the vulnerability of the immature brain to various 
challenges, mediating not only classic cytotoxicity but also alternative functions including 
repair, regeneration and immunosuppression, owing to their ability to acquire diverse 
activation states or phenotypes (Chhor et al., 2013). Their exacerbated activation may 
reverse their beneficial physiological properties, impairing neurogenesis and myelination and 
leading to neuronal and axonal death (Pierre et al., 2017). Some microglia functions have 
been shown to be required for myelination: an excessive microglial activation is usually 
associated with a reduction in oligodendrocyte progenitors, a maturational arrest of the 
oligodendroglial lineage and hypo-myelination (Favrais et al., 2011).  
Although excessive microglial activation is linked to injury, microglial depletion is also 
associated with adverse effects in the developing brain (Faustino et al., 2011; Fernandez-
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Lopez et al., 2016). The colonization of the human brain by microglial cells during fetal life, 
between 12 and 24 GW, leads to clusters of activated microglia in the corpus callosum, the 
axonal crossroads and the periventricular white matter, all areas usually injured in 
neonates(Verney et al., 2012). FGR, which usually occurs at 18-24 GW and during the third 
trimester, could have a strong impact on the microglial cell lineage during this critical period. 
Some mouse models of genetic disruptions of microglial IL18 (Hedtjarn et al., 2002) or of 
galectin 3, interfering with the pro-inflammatory response(Burguillos et al., 2015), suggest 
that a finely tuned modulation of microglial activation through specific pathways (i.e. OXTR 
activation) rather than its global inhibition should be considered as an important therapeutic 
target to protect the developing brain. 
Anti-inflammatory effects of carbetocin are probably responsible for the protection against the 
consequences of LPD+IL1β on myelination, seen not only at the histological level but also at 
the functional level as evidenced by functional ultrasound imaging (fUS) and behavioral 
testing. We have already reported the high sensitivity of fUS technology not only in rodents 
(Rideau Batista Novais et al., 2016) but also in human neonates(Demene et al., 2017). fUS 
offers a valuable combination of penetration and spatiotemporal resolution unique for 
translational studies and appears to be a promising novel brain imaging modality in the field 
of perinatal medicine (Demene et al., 2017). Here, long-term alterations in brain connectivity 
in response to the LPD+IL1β challenge and the beneficial effect of early carbetocin treatment 
were associated with changes in behavior in the open-field test and cognitive abilities in the 
Y-maze test. These results are in agreement with the microstructural changes in gray matter 
and the decreased connectivity previously reported in association with increased anxiety-like 
behavior and reduced attention and memory performance in a rabbit model of growth-
restriction(Illa et al., 2013). Interestingly, altered patterns of brain connectivity have also been 
correlated with motor, cognitive and behavioral outcomes in human children born growth-
restricted (Batalle et al., 2012).  
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In addition to structural damages, neuroinflammation is a common feature in the 
development of many neuropsychiatric diseases including autistic spectrum disorders (ASD), 
depressive and psychotic syndromes, and Alzheimer disease. Most of these disorders, in the 
context of the Developmental Origins of Health and Disease (DOHaD) framework, may 
originate in the perinatal life through exposure to stress, trauma and/or inflammation, all of 
which able to program individuals for an enduring constitutive vulnerability to central 
inflammatory responses (Flinkkila, Keski-Rahkonen, Marttunen, & Raevuori, 2016). Based on 
the present study, we speculate that the reduced OXT tonus provoked by LPD+IL1β 
exposure could be a starting point for a pro-inflammatory trajectory leading to increased 
vulnerability to develop future neuropsychiatric disorders, a frequent co-morbidity in infants 
born preterm or following FGR. Restoring central OXT tonus early in life could thus be 
beneficial to neurobehavioral outcome in these infants exposed to perinatal inflammation. 
Supporting this hypothesis, studies showed that the social behavior alterations observed in a 
mouse model of ASD are causally linked to the OXT system (Penagarikano et al., 2015). 
In conclusion, this study shows that modulation of activated microglia by carbetocin, a long-
lasting brain permeant OXTR agonist, confers neuroprotection of the immature brain towards 
perinatal insult. These findings suggest a key role for the OXT system as a promising 
therapeutic pathway in preventing deleterious effects of perinatal stress associated with 
preterm birth or fetal growth restriction. 
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Figure legends 
Figure 1: The double-hit rat model associating gestational low protein diet with 
postnatal inflammatory challenge. 
A. Pups from isocaloric low protein diet (LPD, 9% protein) and normal diet (Ctl, 22% protein) 
fed mothers were injected i.p. at postnatal (P) days 1 and 2 twice a day with IL1β. Brain were 
then analyzed for mRNA transcription and protein expression directly or after microglia 
magnetic cell sorting. B. Consequences of the LPD treatment on the hypothalamic HPA and 
oxytocin systems mRNA expression at P1, and of LPD+IL1β treatment on the cortical mRNA 
at P2 and P4 (open circle) and on cortical protein expression at P4 and P10 (full circle). Data 
are means ± SEM. All data were found significant and two-tailed unpaired t-test was used for 
comparisons (See Supplementary Table 1 for detailed numbers, t- and p-values). C, D. 
Arraymining analysis performed on sorted microglial cells at P4, showing a synergistic effect 
of LPD exposure and IL1β treatments (N=3 sample per group). PC denotes Pearson 
Correlation (Meta-gene vs experimental group). E. Clustering focused on the comparison 
between microglial transcripts from LPD+IL1β and controls. F. GSEA analysis of the 
differential hallmarks of up-regulated genes in the comparison LPD+IL1β vs Controls. 
Significantly enriched gene clusters linked to inflammatory responses appeared in the up-
regulated genes. G. Up-regulated genes network on LPD and IL1β treatment. The purple 
color is more intense for the most abundant transcripts.  
Figure 2: Central anti-inflammatory action of early postnatal carbetocin treatment in
vivo.  
A. Representative photomicrographs of Iba1+ cells (red) within cortical white matter of rat 
pups at P4 in the 4 experimental groups. Bars=100 µm; LV: lateral ventricle. B. Carbetocin 
restores the number of Iba1+ ameboid cells per slice within in the white matter of LPD+IL1β 
animals. C. mRNA cortical expression of classical cytotoxic and alternate immunomodulatory 
proteins assessed at P1-P2 in in the 4 experimental groups. All comparisons in B and C 
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were performed using one-way ANOVA followed by Newman-Keuls multiple comparison 
tests when appropriate. * and $ is respect to control and LPD+IL1β respectively. Data are 
means ± SEM. (See Supplementary Table 1 for detailed numbers, F- and p-values). D. 
Microarray analysis of microglia sorted cells reveals a clear clustering in gene expression 
between LPD+IL1β and LPD+IL1β+carbetocin (N=3 per group). E. Venn diagram for up- and 
down-regulated genes in microglia from LPD+IL1β and LPD+IL1β+carbetocin respect to 
control. F. Up- and down-regulated genes network in LPD+IL1β with carbetocin treatment. G. 
GSEA analysis revealed that differential hallmarks gene sets of up-regulated genes by 
LPD+IL1β challenge, are systematically enriched in down regulated genes by carbetocin 
treatment. H. Example of gene sets up-regulated by LPD+IL1β treatment, and corrected by 
carbetocin treatment (TNFα signaling via NFκB). Gene expression ratios of core-induced 
genes were collected. In samples from carbetocin treated-animals, 57 genes of the core 
were down-regulated. The global outcome tends to bring back the genes to a ratio of 1.   
Figure 3: In vitro effects of carbetocin and OXTR antagonist in primary microglial 
cultured cells sorted from control and LPD brains with and without pro-inflammatory 
stimulation.  
A. Representative photomicrographs of primary culture of microglial cells sorted from control 
and LPD brains at P2. Microglial cells were stained with Iba1 in basal condition, after pro-
inflammatory stimulation (IL1β + INFγ) in presence or not of 1µM carbetocin. Bar= 50µm.  
B. Multiplex assay for cytokine concentration measurements in the culture medium of primary 
microglia sorted from LPD-exposed and control animals. Two-tailed unpaired t-test was used 
for comparisons normalized to controls. **: p<0.01, *: p<0.05. Data are means ± SEM.  
C. Microglial cell morphological changes induced by IL1β+INFγ stimulation in presence or 
not of carbetocin in control and LPD groups considering cells area, cells perimeter and cells 
circularity. D. Mean cells area, for each condition, in 3 category of cells area with limit of size 
based on a control microglia in basal condition divided in 3 equal sub-groups. E. Distribution 
of cells number (in percent) for each of the 3 cell size groups for each condition. F. Gene 
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expression of microglia phenotypic markers in primary microglial cultured cells sorted from 
control and LPD brains in basal condition and after IL1β+INFγ stimulation in presence or not 
of carbetocin alone or in combination with the OXTR antagonist (L-368-899). IL6, TNFα, and 
iNOS mRNA (two-way ANOVA, P<0.001 for all). Comparisons were performed using two-
way ANOVA followed by Newman-Keuls multiple comparison tests; *, is respect to basal 
condition in either Ctl or LPD groups, $ is respect to IL1β+INFγ in either Ctl or LPD groups, # 
is respect to same condition in LPD compared to the control group, § is respect to L-368-899 
compared to carbetocin effect. Data are means ± SEM. (See Supplementary Table 1 for 
detailed numbers, t-, F- and p-values).  
Figure 4: Carbetocin effect on cortisol-induced microglia activation in zebrafish. 
A. Experimental set-up and drug exposure to dechorionated one day-old embryos. B. Live 
imaging of microglial cells in 8 dpf Tg[Apo-E-GFP] embryos, in which microglial cells display 
an intense green fluorescent labelling used to follow their morphological changes and 
dynamic behavior in vivo. Anterior is on the right. C. Schematic drawing of the optic tectum, 
region of interest imaged in this study (red square). D. Carbetocin markedly decreases 
expression of cortisone-induced pro-inflammatory cytokines IL1β, TNFα, and IL8. E. 
Carbetocin fully alleviates cortisol-induced shape changes of microglial cells. Scale bars: 
50µm. Lower panel depicts representative 3D Imaris software-reconstruction (Bitplane Inc.) 
of isolated microglial cells for each group. Scale bars: 10µm. F. Quantification of microglia 
cell shape changes in response to the different drugs. Microglial cells of embryos exposed to 
hydrocortisone showed highly significant morphological changes, fully prevented by 
carbetocin. Carbetocin alone in control embryos have no detectable effect. G, H. 
Quantification of microglia processes dynamics (process track displacement and process 
speed) and performed using the Imaris software (Bitplane Inc.). See also supplementary 
Movies S1 to S4 that show the dynamic behavior of microglial processes. All comparisons 
were performed using one-way ANOVA followed by Newman-Keuls multiple comparison 
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tests; *** and $$$ (p<0.001) is respect to control and to hydrocortisone groups, respectively. 
Data are means ± SEM. (See Supplementary Table 1 for detailed numbers, F- and p-values).  
Figure 5: Consequences of LPD+IL1β and carbetocin treatment on myelination. 
A. Representative photomicrographs of MBP immuno-reactivity assessment in the cingular 
and lateral white matter (CWM and LWM, respectively) in P10 animals. B. Quantification of 
MBP, APC and Olig2 immuno-reactivity in response to LPD+IL1β challenge and carbetocin 
treatment. Comparisons were performed using one-way ANOVA followed by Newman-Keuls 
multiple comparison tests when appropriate. * and $ is respect to control and LPD+IL1β 
respectively. Data are means ± SEM. (See Supplementary Table 1 for detailed numbers, F- 
and p-values). 
Figure 6: Consequences of LPD+IL1β and carbetocin treatment on myelination and 
functional intrinsic connectivity of the brain. 
A. fUS imaging consists in the 300 repetitions of UfD image acquired every 2s, resulting in 
10 minutes of resting state imaging data performed two times consecutively for each animal. 
Intensity in one pixel of a UfD image is proportional to the local blood volume. These images 
were registered with a functional rat brain atlas for further regions of interest (ROIs) based 
subdivision. B. Based on this registration 10 ROIs were delineated on each side, resulting in 
a total of 20 ROIs overall. In each of these regions the UfD signal was spatially averaged and 
temporally normalized to calculate Pearson correlation coefficient between every couple of 
signals. In this example, RSD signal is strongly similar on the left and right side (blue and 
purple signals), resulting in a high correlation coefficient (0.87), whereas correlation is quite 
weak between left RSD and left ventral thalamus (blue and pink signals)(corr = 0.24), this 
being interpreted as a low connectivity at that moment between those 2 cerebral structures. 
C. All these correlation coefficients were gathered into a matrix whose levels and spatial 
patterns reflect a degree of cerebral connectivity that can be compared between groups. This 
matrix is symmetrical, and one half is displayed as color for qualitative visual inspection and 
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the other half is displayed as numerical values. The coefficients framed in white correspond 
to the so-called inter-hemispheric connectivity and the coefficients framed in blue correspond 
to the so-called intra-hemispheric connectivity (that can therefore be assessed on both left 
and right side). 
D. Average functional connectivity map in the control and LPD+IL1β animals treated or not 
with carbetocin. Pearson correlation coefficients are indicated for the right and left 
hemisphere in the cortex (RSG, retrosplenial granular cortex; RSD, retrosplenial dysgranular 
cortex; MPtA, medial parietal association cortex; LPtA, lateral parietal association cortex), in 
the hippocampus (Hippo), in the dorsal, ventral and medial thalamic area (Thal D, Thal V and 
Thal M, respectively) and in medial and lateral hypothalamic area (Hypot M and Hypot L, 
respectively). E, F.  Loss of inter-(E) and Intra-(F) hemispheric functional intrinsic connectivity 
in LPD+IL1β animals and correction by early carbetocin treatment. For statistical analyses, 
matrix Pearson coefficients were transformed using a Fisher transformation. Comparisons 
were performed using one-way ANOVA followed by Newman-Keuls multiple comparison 
tests; * and $ is respect to control and LPD+IL1β respectively. Data are means ± SEM. (See 
Supplementary Table 1 for detailed numbers, F- and p-values).  
Figure 7: Behavioral consequences of LPD+IL1β and carbetocin treatment in juvenile 
and adult animals. 
A. Representative track records in the open field (OF) test performed in the 4 experimental 
groups in 28-days old animals. B. Subdivision of the open field area in three complementary 
zones defines as periphery (Periph), intermediate (Inter) and center. All comparisons were 
performed using two-way ANOVA for repeated measures, followed by Bonferroni multiple 
comparison tests when appropriate, * is respect to control, $ respect to LPD+IL1β. Data are 
means ± SEM. (See Supplementary Table 1 for detailed numbers, F- and p-values). C, D. 
Behavior during the acquisition and the retention tasks of the Y-maze performed in the 4 
experimental groups in 2 months old animals. Distance traveled during the 5 first minutes of 
the 15 minutes of habituation period during which only two arms of the Y-maze are available 
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(C). Percentage of time spent in the novel arm during the retention task of the Y-maze, 3 
hours after the acquisition (D). Comparisons were performed using one-way ANOVA 
followed by Newman-Keuls multiple comparison tests; * and $ is respect to control and 
LPD+IL1β respectively. Data are means ± SEM. (See Supplementary Table 1 for detailed 
numbers, F- and p-values).  
Table 1 : Functional network enrichment based on sorted microglia cells transcript 
analysis in LPD+IL1β exposed animals compared to controls. Networks which have 
significantly more interactions than expected are listed as biological processes, cellular 
components and KEGG pathways. 
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Supplementary materials legends 
Supplementary Table 1: 
Detailed numbers, F- and p-values for each Figure. 
Supplementary video S1-S4: 
Movies of microglial cells from Tg[ApoE:GFP] embryos incubated in E3 medium alone (S1) 
or treated with carbetocin (1 µM, S2) or hydrocortisone (1.3 µM, S3) alone or in combination 
(S4), showing the dynamic behaviour of microglia and their filopodes. 
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Figure 1: The double-hit rat model associating gestational low protein diet with postnatal inflammatory 
challenge.  
A. Pups from isocaloric low protein diet (LPD, 9% protein) and normal diet (Ctl, 22% protein) fed mothers 
were injected i.p. at postnatal (P) days 1 and 2 twice a day with IL1β. Brain were then analyzed for mRNA 
transcription and protein expression directly or after microglia magnetic cell sorting. B. Consequences of the 
LPD treatment on the hypothalamic HPA and oxytocin systems mRNA expression at P1, and of LPD+IL1β 
treatment on the cortical mRNA at P2 and P4 (open circle) and on cortical protein expression at P4 and P10 
(full circle). Data are means ± SEM. All data were found significant and two-tailed unpaired t-test was used 
for comparisons (See Supplementary Table 1 for detailed numbers, t- and p-values). C, D. Arraymining 
analysis performed on sorted microglial cells at P4, showing a synergistic effect of LPD exposure and IL1β 
treatments (N=3 sample per group). PC denotes Pearson Correlation (Meta-gene vs experimental group). E. 
Clustering focused on the comparison between microglial transcripts from LPD+IL1β and controls. F. GSEA 
analysis of the differential hallmarks of up-regulated genes in the comparison LPD+IL1β vs Controls. 
Significantly enriched gene clusters linked to inflammatory responses appeared in the up-regulated genes. 
G. Up-regulated genes network on LPD and IL1β treatment. The purple color is more intense for the most 
abundant transcripts.  
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Figure 3: In vitro effects of carbetocin and OXTR antagonist in primary microglial cultured cells sorted from 
control and LPD brains with and without pro-inflammatory stimulation.  
A. Representative photomicrographs of primary culture of microglial cells sorted from control and LPD brains 
at P2. Microglial cells were stained with Iba1 in basal condition, after pro-inflammatory stimulation (IL1β + 
INFγ) in presence or not of 1µM carbetocin. Bar= 50µm.  
B. Multiplex assay for cytokine concentration measurements in the culture medium of primary microglia 
sorted from LPD-exposed and control animals. Two-tailed unpaired t-test was used for comparisons 
normalized to controls. **: p<0.01, *: p<0.05. Data are means ± SEM.  
C. Microglial cell morphological changes induced by IL1β+INFγ stimulation in presence or not of carbetocin 
in control and LPD groups considering cells area, cells perimeter and cells circularity. D. Mean cells area, for 
each condition, in 3 category of cells area with limit of size based on a control microglia in basal condition 
divided in 3 equal sub-groups. E. Distribution of cells number (in percent) for each of the 3 cell size groups 
for each condition. F. Gene expression of microglia phenotypic markers in primary microglial cultured cells 
sorted from control and LPD brains in basal condition and after IL1β+INFγ stimulation in presence or not of 
carbetocin alone or in combination with the OXTR antagonist (L-368-899). IL6, TNFα, and iNOS mRNA (two-
way ANOVA, P<0.001 for all). Comparisons were performed using two-way ANOVA followed by Newman-
Keuls multiple comparison tests; *, is respect to basal condition in either Ctl or LPD groups, $ is respect to 
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IL1β+INFγ in either Ctl or LPD groups, # is respect to same condition in LPD compared to the control group, 
§ is respect to L-368-899 compared to carbetocin effect. Data are means ± SEM. (See Supplementary Table 
1 for detailed numbers, t-, F- and p-values). 
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Figure 5: Consequences of LPD+IL1β and carbetocin treatment on myelination.  
A. Representative photomicrographs of MBP immuno-reactivity assessment in the cingular and lateral white 
matter (CWM and LWM, respectively) in P10 animals. B. Quantification of MBP, APC and Olig2 immuno-
reactivity in response to LPD+IL1β challenge and carbetocin treatment. Comparisons were performed using 
one-way ANOVA followed by Newman-Keuls multiple comparison tests when appropriate. * and $ is respect 
to control and LPD+IL1β respectively. Data are means ± SEM. (See Supplementary Table 1 for detailed 
numbers, F- and p-values).  
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Figure 6: Consequences of LPD+IL1β and carbetocin treatment on myelination and functional intrinsic 
connectivity of the brain.  
A. fUS imaging consists in the 300 repetitions of UfD image acquired every 2s, resulting in 10 minutes of 
resting state imaging data performed two times consecutively for each animal. Intensity in one pixel of a 
UfD image is proportional to the local blood volume. These images were registered with a functional rat 
brain atlas for further regions of interest (ROIs) based subdivision. B. Based on this registration 10 ROIs 
were delineated on each side, resulting in a total of 20 ROIs overall. In each of these regions the UfD signal 
was spatially averaged and temporally normalized to calculate Pearson correlation coefficient between every 
couple of signals. In this example, RSD signal is strongly similar on the left and right side (blue and purple 
signals), resulting in a high correlation coefficient (0.87), whereas correlation is quite weak between left 
RSD and left ventral thalamus (blue and pink signals)(corr = 0.24), this being interpreted as a low 
connectivity at that moment between those 2 cerebral structures. C. All these correlation coefficients were 
gathered into a matrix whose levels and spatial patterns reflect a degree of cerebral connectivity that can be 
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compared between groups. This matrix is symmetrical, and one half is displayed as color for qualitative 
visual inspection and the other half is displayed as numerical values. The coefficients framed in white 
correspond to the so-called inter-hemispheric connectivity and the coefficients framed in blue correspond to 
the so-called intra-hemispheric connectivity (that can therefore be assessed on both left and right side).  
D. Average functional connectivity map in the control and LPD+IL1β animals treated or not with carbetocin. 
Pearson correlation coefficients are indicated for the right and left hemisphere in the cortex (RSG, 
retrosplenial granular cortex; RSD, retrosplenial dysgranular cortex; MPtA, medial parietal association 
cortex; LPtA, lateral parietal association cortex), in the hippocampus (Hippo), in the dorsal, ventral and 
medial thalamic area (Thal D, Thal V and Thal M, respectively) and in medial and lateral hypothalamic area 
(Hypot M and Hypot L, respectively). E, F.  Loss of inter-(E) and Intra-(F) hemispheric functional intrinsic 
connectivity in LPD+IL1β animals and correction by early carbetocin treatment. For statistical analyses, 
matrix Pearson coefficients were transformed using a Fisher transformation. Comparisons were performed 
using one-way ANOVA followed by Newman-Keuls multiple comparison tests; * and $ is respect to control 
and LPD+IL1β respectively. Data are means ± SEM. (See Supplementary Table 1 for detailed numbers, F- 
and p-values).  
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Figure 7: Behavioral consequences of LPD+IL1β and carbetocin treatment in juvenile and adult animals.  
A. Representative track records in the open field (OF) test performed in the 4 experimental groups in 28-
days old animals. B. Subdivision of the open field area in three complementary zones defines as periphery 
(Periph), intermediate (Inter) and center. All comparisons were performed using two-way ANOVA for 
repeated measures, followed by Bonferroni multiple comparison tests when appropriate, * is respect to 
control, $ respect to LPD+IL1β. Data are means ± SEM. (See Supplementary Table 1 for detailed numbers, 
F- and p-values). C, D. Behavior during the acquisition and the retention tasks of the Y-maze performed in 
the 4 experimental groups in 2 months old animals. Distance traveled during the 5 first minutes of the 15 
minutes of habituation period during which only two arms of the Y-maze are available (C). Percentage of 
time spent in the novel arm during the retention task of the Y-maze, 3 hours after the acquisition (D). 
Comparisons were performed using one-way ANOVA followed by Newman-Keuls multiple comparison tests; 
* and $ is respect to control and LPD+IL1β respectively. Data are means ± SEM. (See Supplementary Table
1 for detailed numbers, F- and p-values). 
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Table 1 : Functional network enrichment based on sorted microglia cells transcript 
analysis in LPD+IL1β exposed animals compared to controls. Networks which have 
significantly more interactions than expected are listed as biological processes, cellular 
components and KEGG pathways. 
Number of nodes : 107 
Number of edges : 128 
Average node degree : 2.39 
Average local clustering coefficient : 0.449 
Expected number of edges : 43 
PPI enrichment p-value : 0 
Functional enrichments in the network 
Biological process (GO) 
Pathway ID Pathway description Count in gene set False discovery rate 
GO:0002237 Response to molecule of 
bacterial origin 
16 2.72e-09 
GO:0002682 Regulation of immune system 
process 
30 2.72e-09 
GO:0009607 Response to biotic stimulus 23 2.72e-09 
GO:0009617 Response to bacterium 19 2.72e-09 
GO:0051707 Response to other organism 22 2.72e-09 
Cellular Component (GO) 
Pathway ID Pathway description Count in gene set False discovery rate 
GO:0005764 Lysosome 15 1.63e-05 
GO:0005829 Cytosol 35 0.000789 
GO:0044437 Vacuole part 10 0.00512 
GO:0043202 Lysosomal lumen 5 0.0161 
KEGG Pathways 
Pathway ID Pathway description Count in gene set False discovery rate 
04142 Lysosome 12 4.22e-10 
00531 Glycosaminoglycan 
degradation 
4 0.000363 
04380 Osteoclast differentiation 7 0.000363 
04210 Apoptosis 6 0.000372 
05152 Tuberculosis 7 0.0018 
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Figure 1 Variable t-values
1B AVP t21=2.89
1B CRH t21=2.551
1B OXT t21=3.448
1B OXTR t21=4.017
1B P2, IL1β t15=3.038
1B P2, IL6 t14=5.029
1B P2, TNFα t15=6.342
1B P2, iNOS t13=3.136
1B P2, GR t12=3.96
1B P2, MR t13=2.776
1B P4, IL-1β t14=2.679
1B P4, IL6 t14=2.44
1B P4, TNFα t14=3.057
1B P4, iNOS t12=2.216
1B P4, GR t10=4.513
1B P4, MR t10=2.72
1B P4, Iba1 t11=4.684
1B P10, MBP cing t16=6.052 
1B P10, MBP lat t16=4.167
1B P10, APC cing t15=4.362 
1B P10, APC lat t15=6.469
Figure 2 Variable F-values
2B Iba1 1-way anova F3,21=20.59
2C IL1β 1-way anova F3,31=8.278
2C IL6 1-way anova F3,30=10.26
2C TNFα 1-way anova F3,29=26.22
2C iNOS 1-way anova F3,29=10.26
2C Arg1 1-way anova F3,31=4.982
2C IGF1 1-way anova F3,31=9.97
2C Mrc1 1-way anova F3,30=55.34 
2C Sphk1 1-way anova F3,30=8.664
Student's t-test
ANOVA
Student's t-test
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Figure 3 Variable t-values
3B IL1α t9=3.744
3B IL1β t9=2.374
3B TNF t9=2.276
3B IFN t9=2.981
3B IL12 t9=0.358
3B IL4 t10=2.342
Figure 3 Variable F-values
3C cells area 2-way anova, interaction F2,1291=21,81
3C cells perimeter 2-way anova, interaction F2,1291=21,21
3C cells circularity 2-way anova, interaction F2,1291=9.979
3D <31µm
2
2-way anova, interaction F2,614= 2.419
3D from 31µm
2
 to 45µm
2 
2-way anova, interaction F2,423=0.336
3D >45µm
2
2-way anova, interaction F2,242=2.851
Figure 3 Variable F-values
3F TNFα 2-way anova, interaction F3,67=14.32
3F IL6 2-way anova, interaction F3,67=16.32
3F iNOS 2-way anova, interaction F3,72=10.69
Figure 4 Variable F-values
4D IL1β 1-way anova F3,20=14.92
4D TNFα 1-way anova F3,20=15.19
4D IL-8 1-way anova F3,20=20.6
4F cells surface 1-way anova F3,34=66.18
4F cells volume 1-way anova F3,34=11.56
4F area/volume ratio 1-way anova F3,34=14.98
4F sphericity 1-way anova F3,34=107
4G filopode speed 1-way anova F3,8=194.3
4H filopode displacement length 1-way anova F3,8=3789
ANOVA
ANOVA
ANOVA
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Figure 5 Variable F-values
5B MBP cing 1-way anova F3,32=15.58
5B MBP lat 1-way anova F3,32=9.89
5C APC cing 1-way anova F3,29=21.82
5C APC lat 1-way anova F3,29=21.5
5D Olig2 cing 1-way anova F3,32=0.1949
5D Olig2 lat 1-way anova F3,32=0.6268
Figure 6 Variable F-values
6E Hypot M 1-way anova F3,30=13.35
6E Hypot L 1-way anova F3,30=2.312
6E Thal M 1-way anova F3,30=7.092
6E Thal V 1-way anova F3,30=8.665
6E Thal D 1-way anova F3,30=5.123
6E Hippo 1-way anova F3,30=0.1386
6E LPtA 1-way anova F3,30=13.76
6E MPtA 1-way anova F3,30=20.98
6E RSD 1-way anova F3,30=23.44
6E RSG 1-way anova F3,30=13.1
6F left RSD-RSG 1-way anova F3,30=21.26
6F left MPtA-RSD 1-way anova F3,30=20.84
6F left LPtA-MPtA 1-way anova F3,30=18.88 
6F left Hippo-LPtA 1-way anova F3,30=0.9238
6F left Thal D-Hippo 1-way anova F3,30=2.13
6F left Thal V-Thal D 1-way anova F3,30=19.26
6F left Hypot L-Thal V 1-way anova F3,30=8.763
6F left Hypot M-Hypot L 1-way anova F3,30=24.05
6F left Thal M-Hypot M 1-way anova F3,30=4.48
6F right Thal M-Hypot M 1-way anova F3,30=5.736 
6F right Hypot M-Hypot L 1-way anova F3,30=18.67
6F right Hypot L-Thal V 1-way anova F3,30=13.16 
6F right Thal V-Thal D 1-way anova F3,30=12.64 
6F right Thal D-Hippo 1-way anova F3,30=1.337
6F right Hippo-LPtA 1-way anova F3,30=1.018
ANOVA
ANOVA
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6F right LPtA-MPtA 1-way anova F3,30=14.15 
6F right MPtA-RSD 1-way anova F3,30=20.2 
6F right RSD-RSG 1-way anova F3,30=8.403
Figure 7 Variable F-values
7B Distance traveled 2-way anova, interaction F6,20=2.871
7B Cumulative duration 2-way anova, interaction F6,20=5.641
7B Shifting velocity 2-way anova, interaction F6,20=3.348
7C Distance traveled 1-way anova F3,35=4.699
7D time spent in the novel arm 1-way anova F3,35=4.016
ANOVA
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p-values
Control LPD+IL1β 
P=0.009 11 12
P=0.02 11 12
P=0.002 11 12
P=0.0006 11 12
P=0.008 8 9
P=0.0002 8 8
P<0.0001 8 9
P=0.008 7 8
P=0.002 7 7
P=0.015 8 7
P=0.02 8 8
P=0.03 8 8
P=0.009 8 8
P=0.046 7 7
P=0.001 6 6
P=0.02 6 6
P=0.0007 6 7
P<0.0001 8 10
P=0.0007 8 10
P=0.0006 8 9
P<0.0001 8 9
p-values
Control
Control
+carbetocin
LPD+IL1β 
LPD+IL1β 
+carbetocin
P<0.0001 6 6 7 6
P=0.0003 8 8 10 9
P<0.0001 8 8 10 8
P<0.0001 8 7 10 8
P<0.0001 7 7 10 9
P=0.0062 8 7 10 10
P<0.0001 8 8 10 9
P<0.0001 8 7 10 9
P=0.0003 8 7 10 9
N=number of animals
N=number of animals
N=number of samples
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p-values
Control LPD+IL1β 
P=0.0046 6 5
P=0.0416 6 5
P=0.0489 5 6
P=0.0179 6 5
P=0.7284 5 6
P=0.0412 6 6
p-values
Basal IL1β+INFγ 
IL1β+INFγ+ 
Carbetocin
Basal
P<0.0001 204 224 190 243
P<0.0001 204 224 190 243
P<0.0001 204 224 190 243
P=0.0898 68 144 84 132
P=0.7147 68 63 51 77
P=0.0597 68 17 55 34
p-values
Basal IL1β+INFγ 
IL1β+INFγ
+carbetocin
IL1β+INFγ
+carbetocin          
+L-368-899
P<0.0001 11 10 9 7
P<0.0001 12 10 11 7
P<0.0001 9 9 12 12
p-values
Control
Control
+carbetocin
Hydrocortisone
Hydrocortisone+
carbetocin
P<0.0001 8 6 4 6
P<0.0001 8 6 4 6
P<0.0001 8 6 4 6
P<0.0001 11, (26) 9, (37) 9, (25) 9, (30)
P<0.0001 11, (26) 9, (37) 9, (25) 9, (30)
P<0.0001 11, (26) 9, (37) 9, (25) 9, (30)
P<0.0001 11, (26) 9, (37) 9, (25) 9, (30)
P<0.0001 3, (174) 3, (115) 3, (148) 3, (329)
P<0.0001 3, (174) 3, (115) 3, (148) 3, (329)
Control
N=number of cell culture wells 
Control
N=mRNA extracts with 15 pooled embryos per extract
N=number of cells assessed
N =number of embryos  (n=total number of microglia assessed)
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p-values
Control
Control
+carbetocin
LPD+IL1β 
LPD+IL1β  
+carbetocin
P<0.0001 8 8 10 10
P<0.0001 8 8 10 10
P<0.0001 8 7 9 9
P<0.0001 8 7 9 9
P=0.8991 8 8 10 10
 P=0.603 8 8 10 10
p-values
Control
Control
+carbetocin
LPD+IL1β 
LPD+IL1β  
+carbetocin
P<0.0001 9 7 9 9
P=0.0962 9 7 9 9
P=0.001 9 7 9 9
P=0.0003 9 7 9 9
P=0.0056 9 7 9 9
P=0.9361 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P=0.4413 9 7 9 9
P=0.1172 9 7 9 9
P<0.0001 9 7 9 9
P=0.0003 9 7 9 9
P<0.0001 9 7 9 9
P=0.0103 9 7 9 9
P=0.0032 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P=0.281 9 7 9 9
P=0.3986 9 7 9 9
N=number of animals
N=number of animals
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P<0.0001 9 7 9 9
P<0.0001 9 7 9 9
P=0.0003 9 7 9 9
p-values
Control
Control
+carbetocin
LPD+IL1β 
LPD+IL1β  
+carbetocin
P=0.0202 6 6 6 6
P=0.0003 6 6 6 6
P=0.0091 6 6 6 6
P=0.0074 8 11 11 9
P=0.0148 8 11 11 9
N=number of animals
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IL1β+INFγ 
IL1β+INFγ+ 
Carbetocin
221 215
221 215
221 215
117 75
81 89
23 51
Basal IL1β+INFγ 
IL1β+INFγ
+carbetocin
IL1β+INFγ
+carbetocin          
+L-368-899
9 10 9 10
10 9 8 8
10 10 9 9
LPD
N=number of cell culture wells 
LPD
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